T Kasamatsu
No ORCID on file
· 1 paper in corpus
other
1988
A phase II study of carboplatin was conducted in ovarian cancer by a cooperative study group consisting of 22 institutions nationwide. The overall response rate of 50 evaluable cases was 38.0%. The response rate in cases with no prior chemo…